Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by PharmAla Biotech
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
Today 8:30 EST
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla Completes Shipment of LaNeo™ MDMA to Johns Hopkins
October 02, 2025
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
June 03, 2025
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla Contracts with Partner to Act as US Distributor
March 24, 2025
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
February 27, 2025
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
February 06, 2025
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel
January 20, 2025
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
October 21, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla Launches MDMA Clinical Trial Tool for Researchers
August 22, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
August 09, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
April 05, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
March 27, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
March 20, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
March 18, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
January 24, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
January 08, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
PharmAla Begins Trading on OTCQB
September 06, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
July 31, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
June 09, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health
May 01, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
ASX:VIT
CSE:MDMA
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
February 03, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
CSE:MSET
MSSTF
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today